Ventricular oversensing due to manufacturer-related differences in implantable cardioverter-defibrillator signal processing and sensing lead properties

Europace

Volumn 12, Issue 10, 2010, Pages 1460-1466

  Seegers, Joachim ^a   Zabel, Markus ^a   Lüthje, Lars ^a   Vollmann, Dirk ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Implantable cardioverter defibrillator; Lead; Sensing

Indexed keywords

LEAD;

AGED; ARTICLE; COMPARATIVE STUDY; DEFIBRILLATOR; ECG ABNORMALITY; FEMALE; FOLLOW UP; HEART MUSCLE POTENTIAL; HEART VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; R WAVE; RETROSPECTIVE STUDY; SIGNAL PROCESSING; T WAVE; VENTRICULAR OVERSENSING;

AGED; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77957724660     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq269     Document Type: Article

References (19)

1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities:areport of the American College of Cardiology/American Heart Association Task Forceon Practice Guidelines (Writing Committee toRevise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developedincollaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117: e350-408.
2. Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: Part I. Pacing Clin Electrophysiol 2005;28:1322-46.
3. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
4. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-65.
5. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008;359:999-1008.
6. Weretka S, Michaelsen J, Becker R, Karle CA, Voss F, Hilbel T et al. Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems. Pacing Clin Electrophysiol 2003;26:65-70.
7. Occhetta E, Bortnik M, Magnani A, Francalacci G, Marino P. Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias. Europace 2006;8:863-9.
8. Rauwolf T, Guenther M, Hass N, Schnabel A, Bock M, Braun MU et al. Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions. Europace 2007;9:1041-7.
9. Sweeney MO, Ellison KE, Shea JB, Newell JB. Provoked and spontaneous highfrequency, low-amplitude, respirophasic noise transients in patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2001;12:402-10.
10. Gilliam FR 3rd. T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing. J Cardiovasc Electrophysiol 2006;17:553-6.
11. Srivathsan K, Scott LR, Altemose GT. T-wave oversensing and inappropriate shocks: a case report. Europace 2008;10:552-5.
12. Vollmann D, Luthje L, Zabel M. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism? Heart Rhythm 2009;6:718-9.
13. Barold SS, Herweg B, Gallardo I. Double counting of the ventricular electrogram in biventricular pacemakers and ICDs. Pacing Clin Electrophysiol 2003;26:1645-8.
14. Boriani G, Biffi M, Frabetti L, Parlapiano M, Galli R, Branzi A et al. Cardioverterdefibrillator oversensing due to double counting of ventricular tachycardia electrograms. Int J Cardiol 1998;66:91-5.
15. DeCaprio V, Hurzeler P, Furman S. A comparison of unipolar and bipolar electrograms for cardiac pacemaker sensing. Circulation 1977;56:750-5.
16. Epstein AE, Kay GN, Plumb VJ, Dailey SM, Anderson PG. Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation 1998;98:1517-24.
17. Ino T, Fishbein MC, Mandel WJ, Chen PS, Karagueuzian HS. Cellular mechanisms of ventricular bipolar electrograms showing double and fractionated potentials. J Am Coll Cardiol 1995;26:1080-9.
18. Gunderson BD, Swerdlow CD, Wilcox JM, Hayman JE, Ousdigian KT, Ellenbogen KA. Causes of ventricular oversensing in implantable cardioverter- defibrillators: implications for diagnosis of lead fracture. Heart Rhythm 2010;7:626-33.
19. Tuzcu V. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacementinanadolescent. Pacing Clin Electrophysiol 2007;30:929-32.